GlassScriptPhysician profile
Mitchell A Ahrens
NPI 1407967235
$12,215.68
in general payments reported to CMS, 2019-2025
49 companies · $1,958 in 2025
The $1,958 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,901 · 2020: $423 · 2021: $120 · 2022: $655 · 2023: $5,999 · 2024: $1,159 · 2025: $1,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,281 · Education: $3,020 · Travel and Lodging: $1,465 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,281.17 |
| Education | $3,020.00 |
| Travel and Lodging | $1,465.08 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,782.37 | 2022-2024 | Da Vinci Surgical System |
| Inspire Medical Systems, INC. | $1,045.67 | 2022-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $849.18 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $837.68 | 2019-2025 | Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $513.84 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $398.96 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Jazz Pharmaceuticals INC. | $326.31 | 2019-2025 | |
| Genentech USA, INC. | $274.44 | 2019-2024 | Xolair |
| Regeneron Healthcare Solutions, INC. | $260.57 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $239.88 | 2019-2024 | Yupelri |
| Insmed, INC. | $220.16 | 2019-2025 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $200.00 | 2025 | |
| Grifols USA, LLC | $194.41 | 2019-2025 | Prolastin-C Liquid, Gamunex-C |
| Csl Behring | $164.07 | 2022-2025 | Kcentra |
| Actelion Pharmaceuticals US, INC. | $160.88 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $159.31 | 2019-2025 | |
| Genzyme Corporation | $155.68 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $137.00 | 2019-2025 | Zerbaxa, Winrevair, Recarbrio |
| Axsome Therapeutics, INC. | $104.65 | 2023-2025 | Sunosi |
| Amgen INC. | $102.02 | 2022-2025 | Tezspire |
| Circassia INC. | $97.32 | 2019-2020 | |
| Abbvie INC. | $90.26 | 2022-2025 | Avycaz |
| Noah Medical Corporation | $81.87 | 2025 | Galaxy |
| Astellas Pharma US INC | $81.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $71.87 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $63.03 | 2022-2025 | Acthar |
| Avadel Cns Pharmaceuticals, LLC | $51.62 | 2023-2024 | Lumryz |
| Harmony Biosciences LLC | $50.41 | 2023-2024 | Wakix |
| Viatris Specialty LLC | $50.25 | 2025 | Yupelri |
| Idorsia Pharmaceuticals US INC | $49.23 | 2022-2023 | Quviviq |
| Baxter Healthcare | $47.17 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Sunovion Pharmaceuticals INC. | $45.32 | 2019 | |
| Lilly USA, LLC | $36.68 | 2025 | Zepbound |
| Verona Pharma, INC. | $31.86 | 2025 | Ohtuvayre |
| Philips North America LLC | $29.62 | 2019-2023 | |
| Allergan, INC. | $25.75 | 2019-2020 | |
| Zoll Respicardia, INC. | $20.05 | 2023 | Remede System |
| Boston Scientific Corporation | $19.83 | 2023 | Ams 800 Artificial Urinary Sphincter |
| Janssen Pharmaceuticals, INC | $17.15 | 2019 | |
| Electromed, INC. | $17.09 | 2019 | |
| Siemens Medical Solutions USA, INC. | $16.66 | 2024 | Cios Spin |
| Chiesi USA, INC. | $14.92 | 2019 | |
| Ethicon US, LLC | $14.27 | 2019 | |
| Pulmonx Corporation | $13.37 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.11 | 2023 | |
| Fisher & Paykel Healthcare INC | $12.84 | 2019 | |
| Shire North American Group INC | $12.76 | 2019 | |
| Biomerieux INC | $9.26 | 2019 | |
| Veran Medical Technologies, INC. | $3.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Ahrens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.